As the peptide GE11 is a specific EGFR ligand, targeted let-7a delivery to EGFR expressing breast cancer xenografts in mice, was achieved by intravenous administration of miRNA laden exosomes which co-expressed GE11 at their surface. This evidence concerns the gene EGFR and breast carcinoma.